122 related articles for article (PubMed ID: 8852337)
1. Ergosterol biosynthesis inhibition: a target for antifungal agents.
Barrett-Bee K; Dixon G
Acta Biochim Pol; 1995; 42(4):465-79. PubMed ID: 8852337
[TBL] [Abstract][Full Text] [Related]
2. Antifolates as antimycotics? Connection between the folic acid cycle and the ergosterol biosynthesis pathway in Candida albicans.
Navarro-Martínez MD; Cabezas-Herrera J; Rodríguez-López JN
Int J Antimicrob Agents; 2006 Dec; 28(6):560-7. PubMed ID: 17046206
[TBL] [Abstract][Full Text] [Related]
3. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
Navarro-Martínez MD; García-Cánovas F; Rodríguez-López JN
J Antimicrob Chemother; 2006 Jun; 57(6):1083-92. PubMed ID: 16585130
[TBL] [Abstract][Full Text] [Related]
4. Biochemical basis for the activity and selectivity of oral antifungal drugs.
Vanden Bossche H; Marichal P; Gorrens J; Coene MC
Br J Clin Pract Suppl; 1990 Sep; 71():41-6. PubMed ID: 2091733
[TBL] [Abstract][Full Text] [Related]
5. Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida.
Ahmad A; Khan A; Manzoor N; Khan LA
Microb Pathog; 2010 Jan; 48(1):35-41. PubMed ID: 19835945
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of ergosterol biosynthesis as potential antifungal drugs.
Balliano G; Viola F; Cattel L
Ital J Biochem; 1989; 38(4):299A-300A. PubMed ID: 2684906
[No Abstract] [Full Text] [Related]
7. [Attack point of ergosterol biosynthesis. Drugs and pharmacology].
Bracher F
Pharm Unserer Zeit; 2003; 32(2):118-23. PubMed ID: 12677964
[No Abstract] [Full Text] [Related]
8. Effects of antifungal agents on ergosterol biosynthesis in Candida albicans and Trichophyton mentagrophytes: differential inhibitory sites of naphthiomate and miconazole.
Morita T; Nozawa Y
J Invest Dermatol; 1985 Nov; 85(5):434-7. PubMed ID: 3902987
[TBL] [Abstract][Full Text] [Related]
9. [Sterol level in Saccharomyces cerevisiae mutants with altered ergosterol biosynthesis].
Mikhaĭlova NP; Ogorodnikova TE; V'iunov KA
Prikl Biokhim Mikrobiol; 1990; 26(3):360-3. PubMed ID: 2202986
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ergosterol synthesis by novel antifungal compounds targeting C-14 reductase.
Hata M; Ishii Y; Watanabe E; Uoto K; Kobayashi S; Yoshida K; Otani T; Ando A
Med Mycol; 2010 Jun; 48(4):613-21. PubMed ID: 20392153
[TBL] [Abstract][Full Text] [Related]
11. A novel sequence element is involved in the transcriptional regulation of expression of the ERG1 (squalene epoxidase) gene in Saccharomyces cerevisiae.
Leber R; Zenz R; Schröttner K; Fuchsbichler S; Pühringer B; Turnowsky F
Eur J Biochem; 2001 Feb; 268(4):914-24. PubMed ID: 11179957
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol.
Bammert GF; Fostel JM
Antimicrob Agents Chemother; 2000 May; 44(5):1255-65. PubMed ID: 10770760
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.
Sardari S; Mori Y; Kurosawa T; Daneshtalab M
Can J Microbiol; 2003 May; 49(5):344-9. PubMed ID: 12897828
[TBL] [Abstract][Full Text] [Related]
14. Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate.
Ryder NS; Frank I; Dupont MC
Antimicrob Agents Chemother; 1986 May; 29(5):858-60. PubMed ID: 3524433
[TBL] [Abstract][Full Text] [Related]
15. Overexpression or Deletion of Ergosterol Biosynthesis Genes Alters Doubling Time, Response to Stress Agents, and Drug Susceptibility in
Bhattacharya S; Esquivel BD; White TC
mBio; 2018 Jul; 9(4):. PubMed ID: 30042199
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ergosterol biosynthesis is not accompanied by a change in fatty acid composition in Saccharomyces cerevisiae treated with the antifungal agent 6-amino-2-n-pentylthiobenzothiazole.
Kuchta T; Léka C; Kubinec R; Russell NJ
FEMS Microbiol Lett; 1997 May; 150(1):43-7. PubMed ID: 9163904
[TBL] [Abstract][Full Text] [Related]
17. Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae--a review.
Lees ND; Skaggs B; Kirsch DR; Bard M
Lipids; 1995 Mar; 30(3):221-6. PubMed ID: 7791529
[TBL] [Abstract][Full Text] [Related]
18. Terbinafine: mode of action and properties of the squalene epoxidase inhibition.
Ryder NS
Br J Dermatol; 1992 Feb; 126 Suppl 39():2-7. PubMed ID: 1543672
[TBL] [Abstract][Full Text] [Related]
19. Antifungal agents: mode of action in yeast cells.
Carrillo-Muñoz AJ; Giusiano G; Ezkurra PA; Quindós G
Rev Esp Quimioter; 2006 Jun; 19(2):130-9. PubMed ID: 16964330
[TBL] [Abstract][Full Text] [Related]
20. Mode of action of anti-Candida drugs: focus on terconazole and other ergosterol biosynthesis inhibitors.
Vanden Bossche H; Marichal P
Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1193-9. PubMed ID: 1951574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
